Kyntra Bio, Inc. Insider Trading

KYNB

⊜ Compare

Last 12 months

Insiders bought 54K on the open market and sold nothing.

Net open-market

+54K

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

May 2026

May 14, 2026

Get an email when KYNB's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 14	Thane Wettig CEO	Bought	2,800	$7.09	20K	11%	Form 4
Nov 13, 2025 – Nov 17, 2025	Thane Wettig CEO	Bought 2 parts	3,700	$9.12 average	34K	17%	Form 4
Jun 30, 2025	James A Schoeneck Director	Bought	23,567	$5.07	119K	146%	Form 4
Mar 24, 2025	Thane Wettig CEO	Bought	145,000	$0.35	51K	36%	Form 4
Mar 20, 2025 – Mar 21, 2025	James A Schoeneck Director	Bought 2 parts	300,000	$0.35 average	105K	293%	Form 4

May 14
Thane Wettig
CEO · bought 2,800 at $7.09
20K
11% of stake
Nov 13, 2025 – Nov 17, 2025
Thane Wettig
CEO · bought 3,700 at avg $9.12
34K
17% of stake
Jun 30, 2025
James A Schoeneck
Director · bought 23,567 at $5.07
119K
146% of stake
Mar 24, 2025
Thane Wettig
CEO · bought 145,000 at $0.35
51K
36% of stake
Mar 20, 2025 – Mar 21, 2025
James A Schoeneck
Director · bought 300,000 at avg $0.35
105K
293% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KYNB, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with KYNB

CompareIntrinsic value

BOLTBolt Biotherapeutics Inc.

$6.54-0.46%25

ENSCEnsysce Biosciences Inc.

$0.37-2.20%40

INMInMed Pharmaceuticals Inc.

$17.50+4.17%40

PCYNProcyon Corporation

$0.18+0.00%20

ATAIAtaiBeckley Inc.

$0.61-1.61%40

PRPHProPhase Labs Inc.

$0.01-42.00%0

CPHIChina Pharma Holdings Inc.

$0.59-3.28%15

MRKRMarker Therapeutics, Inc.

$1.01+3.06%25

Spot a number that looks wrong? Check it in KYNB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KYNB

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.